Opens in a new tab

10xGenomics v NanoString (CFI, 5 December 2023)

Date5 December 2023
CourtCFI
DivisionMunich (DE) Local Division
Type of actionApplication for provisional measures
Case number(s)UPC_CFI_2/2023
Registry referenceORD_577241/2023 · UPC_CFI_2/2023
Parties10xGenomics Inc., President and Fellows of Harvard College v. NanoString Technologies Inc. et al.

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 5 December 2023 (UPC_CFI_2/2023, ACT_459746/2023, App_577241/2023), the Munich Local Division (judges Zigann, presiding, Pichlmaier, rapporteur, Kupecz and Enderlin, technically qualified) imposed on NanoString Technologies Inc., NanoString Technologies Germany GmbH and NanoString Technologies Netherlands B.V. a penalty payment totalling EUR 100,000, payable to the Court, for breach of the provisional measures order of 19 September 2023 granted to 10x Genomics, Inc. and the President and Fellows of Harvard College on the basis of EP 4 108 782.

The order clarifies the conditions for enforcing UPC provisional measures: service through the CMS is enough, without any prior national formality. It also sets out the criteria for fixing a penalty payment, which sanctions fault, and grants leave to appeal, the decision being among the first of its kind.

Facts and procedure

The order of 19 September 2023, served through the CMS on 20 September, prohibited in particular use of the patented method and offers of CosMx devices, reagents and probes in the listed states unless accompanied by a prominent disclaimer, under a penalty of up to EUR 250,000 per breach, and was immediately enforceable. On 28 September 2023 the applicants sought penalties for online offers, the promotion of events, user manuals and an offer of laboratory tours. The respondents argued that the national enforcement requirements (service, prior notice) were not met and denied any breach. The division decided without an oral hearing.

The applicable law

Art. 82(4) UPCA and Rule 354.4 RoP allow penalty payments payable to the Court for breach of an order. The conditions for a penalty are laid down exhaustively in Art. 82(4) UPCA, national enforcement law comes into play only if the penalty is not paid. Offering is understood within Art. 25(a) UPCA. Costs follow Art. 69 UPCA and Rule 118.5 RoP, applied by analogy.

Question

Is a provisional measures order served through the CMS enforceable without further formality, which publications amount to a breach, and how is the amount of the penalty to be fixed?

Decision

The order was enforceable upon service through the CMS, under Rule 354.1 RoP and its own terms: no prior notice, national enforcement order or party service was required, Rule 118.8 RoP does not apply to orders under Art. 62 UPCA.

The following were breaches: an offer on the website of the CX-Lab in Amsterdam to carry out the method, which a later disclaimer did not cure, a CosMx product page offering shipment without the required disclaimer, which was only added after 21 September 2023, promotion of summits in Paris and Frankfurt whose disclaimer was made confusing by wording suggesting unrestricted use, manuals with a disclaimer too small to be prominent, and the offer of laboratory tours expressly covering RNA analysis. The website content is attributed to the respondents.

A penalty payment serves both a coercive and a quasi-criminal purpose and requires fault. Its amount reflects the nature, extent and duration of the breaches, the degree of fault, the benefit obtained and the risk of further infringement. The breaches, traced to a single cause (the website design) and at least grossly negligent, are weighed against the short time since service and the corrections made, but also against the high revenue per instrument and the reagent market. The respondents, each liable for the whole, bear the costs, the amounts requested being only a proposal. The value of the penalty proceedings is set at EUR 250,000.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 25(a), Art. 62, Art. 69(1) and (2), Art. 73(2)(b)(ii) and Art. 82(3) and (4)
Rules of Procedure
Rules 118.5, 118.8, 220.2, 264, 352.1, 354.1 and 354.4
Case law cited
myStromer AG v Revolt Zycling AG, Düsseldorf Local Division, 18 October 2023

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Application for a preliminary injunction, Order to preserve evidence (UPC).

Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_2/2023 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 23 June 2023 10x Genomics v NanoString (CFI, UPC_CFI_2/2023, 23 June 2023) Application for provisional measures · UPC_CFI_2/2023

    Les délais de réponse (14 juillet 2023) et de réplique (4 août 2023) sont fixés et les parties convoquées à l'audience des 5 et 6 septembre 2023.

  2. 27 June 2023 10x Genomics v NanoString (CFI, UPC_CFI_2/2023, 27 June 2023) Application for provisional measures · UPC_CFI_2/2023

    Les demanderesses sont invitées à téléverser dans le CMS les pièces jointes à leur demande de mesures provisoires.

  3. 30 June 2023 10x Genomics v NanoString (CFI, UPC_CFI_2/2023, 30 June 2023) Application for provisional measures · UPC_CFI_2/2023

    Les moyens du mémoire préventif rédigé en anglais doivent être repris dans la réponse en allemand, avec les pièces sous leur numérotation d'origine.

  4. 6 July 2023 10x Genomics v NanoString (CFI, UPC_CFI_2/2023, 6 July 2023) Application for provisional measures · UPC_CFI_2/2023

    Il n'est pas nécessaire de déposer la traduction des pièces rédigées en anglais.

  5. 10 July 2023 10x Genomics v NanoString (CFI, 10 July 2023) Application for provisional measures · UPC_CFI_2/2023

    Les délais d'écritures fixés le 23 juin 2023 sont prorogés au 21 juillet 2023 pour les défenderesses et au 11 août 2023 pour les demanderesses.

  6. 19 September 2023 10x Genomics v NanoString (CFI, 19 September 2023) Application for provisional measures · UPC_CFI_2/2023

    La division locale de Munich fait droit pour l'essentiel à la demande de mesures provisoires de 10x Genomics et Harvard : contrefaçon directe et indirecte d'EP 4 108 782, validité établie selon une probabilité prépondérante, urgence et nécessité retenues, aucune licence due, interdiction dans dix-sept États sans sûreté…

  7. 5 December 2023 10xGenomics v NanoString (CFI, 5 December 2023) Application for provisional measures · UPC_CFI_2/2023

What the record states

Nature of the act
Application for provisional measures
Outcome (Dhenne Avocats summary)
Une astreinte de 100 000 euros au total est infligée aux défenderesses pour plusieurs violations de l'ordonnance de mesures provisoires du 19 septembre 2023, exécutoire dès sa signification par le CMS. L'appel est autorisé.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 108 782
Compositions and methods for analyte detection
recorded proprietor: Harvard University
Mentioned in the analysis (role not qualified)
Also mentioned in 18 other decision(s): NanoString Technologies v 10x Genomics (CoA, 11 March 2024) · 10x Genomics v NanoString (CFI, 19 September 2023) · 10x Genomics v Bruker Spatial Biology (CFI, 11 April 2025) · 10x Genomics v Vizgen (CoA, 11 March 2025) · 10x Genomics v Vizgen (CoA, 5 March 2025) · 10x Genomics v Vizgen (CFI, 20 December 2024) · NanoString Technologies v 10x Genomics (CoA, 10 December 2024) · 10x Genomics v Vizgen (CFI, 1 November 2024)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.